These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36551250)

  • 1. Structural Basis of Botulinum Toxin Type F Binding to Glycosylated Human SV2A:
    Azzaz F; Hilaire D; Fantini J
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of botulinum neurotoxin serotype A1 binding to human SV2A or SV2C receptors.
    Azzaz F; Hilaire D; Fantini J
    Chem Biol Interact; 2023 Mar; 373():110384. PubMed ID: 36754227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
    Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
    J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
    Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
    Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
    Peng L; Tepp WH; Johnson EA; Dong M
    PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
    Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER
    Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
    Rummel A
    Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.
    Weisemann J; Stern D; Mahrhold S; Dorner BG; Rummel A
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1.
    Mahrhold S; Bergström T; Stern D; Dorner BG; Åstot C; Rummel A
    Biochem J; 2016 Sep; 473(17):2645-54. PubMed ID: 27313224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding.
    Gustafsson R; Zhang S; Masuyer G; Dong M; Stenmark P
    Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29649119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into the interaction of botulinum neurotoxin a with its neuronal receptor SV2C.
    Li X; Brunner C; Wu Y; Leka O; Schneider G; Kammerer RA
    Toxicon; 2020 Feb; 175():36-43. PubMed ID: 31783045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2.
    Liu Z; Lee PG; Krez N; Lam KH; Liu H; Przykopanski A; Chen P; Yao G; Zhang S; Tremblay JM; Perry K; Shoemaker CB; Rummel A; Dong M; Jin R
    Nat Commun; 2023 Apr; 14(1):2338. PubMed ID: 37095076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
    Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
    J Biol Chem; 2012 Nov; 287(48):40806-16. PubMed ID: 23027864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A.
    Yamagata A; Ito K; Suzuki T; Dohmae N; Terada T; Shirouzu M
    Nat Commun; 2024 Apr; 15(1):3027. PubMed ID: 38637505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H.
    Yao G; Lam KH; Perry K; Weisemann J; Rummel A; Jin R
    Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28282873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Feet on the Membrane: Uptake of Clostridial Neurotoxins.
    Rummel A
    Curr Top Microbiol Immunol; 2017; 406():1-37. PubMed ID: 27921176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC.
    Zhang S; Berntsson RP; Tepp WH; Tao L; Johnson EA; Stenmark P; Dong M
    Nat Commun; 2017 Nov; 8(1):1637. PubMed ID: 29158482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E.
    Masuyer G; Davies JR; Stenmark P
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding peptide competitive inhibition of botulinum neurotoxin A binding to SV2 protein via molecular dynamics simulations.
    Chang S; He HQ; Shen L; Wan H
    Biopolymers; 2015 Oct; 103(10):597-608. PubMed ID: 26178648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
    Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
    Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.